• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

刚地弓形虫:使用重组蛋白的鼻内疫苗对BALB/c小鼠脑囊肿形成的评估

Toxoplasma gondii: evaluation of an intranasal vaccine using recombinant proteins against brain cyst formation in BALB/c mice.

作者信息

Igarashi M, Kano F, Tamekuni K, Machado R Z, Navarro I T, Vidotto O, Vidotto M C, Garcia J L

机构信息

Protozoology Laboratory, Departamento de Medicina Veterinária Preventiva, Universidade Estadual de Londrina, Postal Box 6001, 86050-970 Londrina, PR, Brazil.

出版信息

Exp Parasitol. 2008 Mar;118(3):386-92. doi: 10.1016/j.exppara.2007.10.002. Epub 2007 Oct 11.

DOI:10.1016/j.exppara.2007.10.002
PMID:18154953
Abstract

The purpose of this work was to evaluate protective activity against brain cyst formation in BALB/c mice intranasally vaccinated with recombinant proteins from Toxoplasma gondii. The recombinant proteins rROP2, rGRA5 and rGRA7 were used in vaccine preparation. Thirty-three female mice were divided into three groups, these animals received two doses by intranasal route at days 0 and 21 as follows; group 1 (G1, n=11) received 12.5 microg of each recombinant protein plus 0.5 microg of cholera toxin, group 2 (G2, n=11) received phosphate buffer saline (PBS) plus 0.5 microg of cholera toxin, and group 3 (G3, n=11) received PBS only. At challenge day (day 33) three animals from each group were euthanatized for IgA measure from intestine. Mice were infected orally with 50 cysts from the VEG strain at day 33. At challenge day the G1 animals had high immunoglobulin A levels, however, they only showed IgG antibody titers against rROP2 and rGRA7. Animals from G1 also exhibited strong resistance to cyst formation compared with the control group (G3, P<0.05). However, we did not observe differences in protection against brain cyst formation between G1 and G2 (P>0.1). These results indicate that intranasal immunization in BALB/c mice with recombinant proteins rROP2, rGRA5 and rGRA7 associated with cholera toxin induced partial protection, when compared with G3, against tissue cyst formation after oral infection with tissue cysts from T. gondii.

摘要

本研究旨在评估用刚地弓形虫重组蛋白经鼻内接种BALB/c小鼠后对脑囊肿形成的保护作用。疫苗制备中使用了重组蛋白rROP2、rGRA5和rGRA7。33只雌性小鼠分为三组,这些动物在第0天和第21天经鼻内途径接受两剂接种,具体如下:第1组(G1,n = 11)接受12.5微克每种重组蛋白加0.5微克霍乱毒素,第2组(G2,n = 11)接受磷酸盐缓冲盐水(PBS)加0.5微克霍乱毒素,第3组(G3,n = 11)仅接受PBS。在攻毒日(第33天),每组处死三只动物以测量肠道中的IgA。在第33天,小鼠经口感染来自VEG株的50个囊肿。在攻毒日,G1组动物的免疫球蛋白A水平较高,然而,它们仅显示出针对rROP2和rGRA7的IgG抗体滴度。与对照组(G3,P<0.05)相比,G1组动物对囊肿形成也表现出较强的抵抗力。然而,我们未观察到G1组和G2组在预防脑囊肿形成方面存在差异(P>0.1)。这些结果表明,与G3组相比,用重组蛋白rROP2、rGRA5和rGRA7联合霍乱毒素经鼻内免疫BALB/c小鼠,在经口感染刚地弓形虫组织囊肿后可诱导部分保护作用,防止组织囊肿形成。

相似文献

1
Toxoplasma gondii: evaluation of an intranasal vaccine using recombinant proteins against brain cyst formation in BALB/c mice.刚地弓形虫:使用重组蛋白的鼻内疫苗对BALB/c小鼠脑囊肿形成的评估
Exp Parasitol. 2008 Mar;118(3):386-92. doi: 10.1016/j.exppara.2007.10.002. Epub 2007 Oct 11.
2
Protective activity against oocyst shedding in cats vaccinated with crude rhoptry proteins of the Toxoplasma gondii by the intranasal route.经鼻内途径用刚地弓形虫粗棒状体蛋白对猫进行疫苗接种后对卵囊排出的保护作用。
Vet Parasitol. 2007 Apr 30;145(3-4):197-206. doi: 10.1016/j.vetpar.2007.01.007. Epub 2007 Feb 12.
3
Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.评价三种由弓形虫表面和分泌抗原组成的重组多抗原疫苗在实验性弓形虫病小鼠模型中的效果。
Vaccine. 2011 Jan 17;29(4):821-30. doi: 10.1016/j.vaccine.2010.11.002. Epub 2010 Nov 16.
4
Partial protection against tissue cysts formation in pigs vaccinated with crude rhoptry proteins of Toxoplasma gondii.用刚地弓形虫粗制棒状体蛋白对猪进行疫苗接种可部分预防组织囊肿的形成。
Vet Parasitol. 2005 May 15;129(3-4):209-17. doi: 10.1016/j.vetpar.2005.01.006.
5
Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice.刚地弓形虫:三种由重组 ROP2、ROP4、GRA4 和 SAG1 蛋白组成的三价抗原鸡尾酒对 BALB/c 小鼠慢性弓形虫病的疫苗潜力。
Exp Parasitol. 2012 May;131(1):133-8. doi: 10.1016/j.exppara.2012.02.026. Epub 2012 Mar 14.
6
[Intranasal immunization with mucosal complex vaccine protects mice against Toxoplasma gondii].鼻内接种黏膜复合疫苗可保护小鼠免受刚地弓形虫感染
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2007 Aug;25(4):290-4.
7
Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis.刚地弓形虫:重组棒状体蛋白2和棒状体蛋白4在小鼠实验性弓形虫病中的免疫原性和保护效力
Exp Parasitol. 2009 Sep;123(1):81-9. doi: 10.1016/j.exppara.2009.06.002. Epub 2009 Jun 7.
8
Toxoplasma gondii: protective effect of an intranasal SAG1 and MIC4 DNA vaccine in mice.刚地弓形虫:鼻内接种SAG1和MIC4 DNA疫苗对小鼠的保护作用
Exp Parasitol. 2009 Jul;122(3):226-32. doi: 10.1016/j.exppara.2009.04.002. Epub 2009 Apr 12.
9
Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.用减毒活重组鼠伤寒沙门氏菌进行口服免疫可保护小鼠免受刚地弓形虫感染。
Parasite Immunol. 2005 Jan-Feb;27(1-2):29-35. doi: 10.1111/j.1365-3024.2005.00738.x.
10
[Immune response elicited by the recombinant protein and plasmid DNA of complex antigen ROP2-SAG1 from Toxoplasma gondii].[弓形虫复合抗原ROP2-SAG1重组蛋白及质粒DNA引发的免疫反应]
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2010 Oct 30;28(5):359-63.

引用本文的文献

1
Development of a hexavalent recombinant protein vaccine adjuvanted with Montanide ISA 50 V and determination of its protective efficacy against acute toxoplasmosis.研制了一种与 Montanide ISA 50V 佐剂偶联的六价重组蛋白疫苗,并测定其对急性弓形虫病的保护效力。
BMC Infect Dis. 2020 Jul 10;20(1):493. doi: 10.1186/s12879-020-05220-2.
2
Rhoptry antigens as vaccine target.棒状体抗原作为疫苗靶点。
Clin Exp Vaccine Res. 2019 Jan;8(1):4-26. doi: 10.7774/cevr.2019.8.1.4. Epub 2019 Jan 31.
3
Discovery of new Toxoplasma gondii antigenic proteins using a high throughput protein microarray approach screening sera of murine model infected orally with oocysts and tissue cysts.
采用高通量蛋白微阵列方法筛选经口感染卵囊和组织囊的鼠模型血清,发现新的弓形虫抗原蛋白。
Parasit Vectors. 2018 Jul 4;11(1):393. doi: 10.1186/s13071-018-2934-1.
4
Evaluation of Immunoprotection Conferred by the Subunit Vaccines of GRA2 and GRA5 against Acute Toxoplasmosis in BALB/c Mice.评价GRA2和GRA5亚单位疫苗对BALB/c小鼠急性弓形虫病的免疫保护作用。
Front Microbiol. 2016 Apr 27;7:609. doi: 10.3389/fmicb.2016.00609. eCollection 2016.
5
Evaluation of Immunogenicity of Cocktail DNA Vaccine Containing Plasmids Encoding Complete GRA5, SAG1, and ROP2 Antigens of Toxoplasma gondii in BALB/C Mice.含编码刚地弓形虫完整GRA5、SAG1和ROP2抗原质粒的联合DNA疫苗在BALB/C小鼠中的免疫原性评估
Iran J Parasitol. 2015 Oct-Dec;10(4):590-8.
6
Evaluation of a recombinant rhoptry protein 2 enzyme-linked immunoassay for the diagnosis of toxoplasmosis acquired during pregnancy.评估重组棒状体蛋白2酶联免疫吸附测定法用于诊断孕期获得性弓形虫病。
Mem Inst Oswaldo Cruz. 2015 Sep;110(6):732-8. doi: 10.1590/0074-02760150069.
7
Recombinant dense granular protein (GRA5) for detection of human toxoplasmosis by Western blot.用于蛋白质印迹法检测人类弓形虫病的重组致密颗粒蛋白(GRA5)
Biomed Res Int. 2014;2014:690529. doi: 10.1155/2014/690529. Epub 2014 May 29.
8
Intranasal immunisation with recombinant Toxoplasma gondii actin partly protects mice against toxoplasmosis.用重组弓形虫肌动蛋白进行鼻内免疫可部分保护小鼠免受弓形虫病感染。
PLoS One. 2013 Dec 27;8(12):e82765. doi: 10.1371/journal.pone.0082765. eCollection 2013.
9
Molecular cloning, sequencing, and biological characterization of GRA4 gene of Toxoplasma gondii.弓形虫 GRA4 基因的分子克隆、测序和生物学特征。
Parasitol Res. 2013 Jul;112(7):2487-94. doi: 10.1007/s00436-013-3414-3. Epub 2013 Apr 10.
10
Construction and In vitro Expression Analyses of a DNA Plasmid Encoding Dense Granule GRA5 Antigen of Toxoplasma gondii.编码刚地弓形虫致密颗粒GRA5抗原的DNA质粒的构建及体外表达分析
Avicenna J Med Biotechnol. 2011 Jul;3(3):135-41.